Patents by Inventor Cynthia Scanlan

Cynthia Scanlan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090263394
    Abstract: Polynucleotide molecules and polypeptide molecules A34 and A33-like 3 are described, as well as antibodies to polypeptide molecules A34 and A33-like 3. Also described are methods of detecting cancers expressing these polypeptides, and methods and kits for diagnosing said cancers, and methods of inhibiting effects of a cancer in a patient.
    Type: Application
    Filed: February 17, 2009
    Publication date: October 22, 2009
    Applicant: LUDWIG INSTITUTE FOR CANCER RESEARCH
    Inventors: Matthew Scanlan, Cynthia Scanlan, Gerd Ritter, Lioyd Old, Achim Jungbluth
  • Patent number: 7521543
    Abstract: Polynucleotide molecules and polypeptide molecules A34 and A33-like 3 are described, as well as antibodies to polypeptide molecules A34 and A33like 3. Also described are methods of detecting cancers expressing these polypeptides, and methods and kits for diagnosing said cancers, and methods of inhibiting effects of a cancer in a patient.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: April 21, 2009
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Cynthia Scanlan, legal representative, Gerd Ritter, Lloyd Old, Achim Jungbluth, Matthew Scanlan
  • Publication number: 20060292154
    Abstract: Polynucleotide molecules and polypeptide molecules A34 and A33-like 3 are described, as well as antibodies to polypeptide molecules A34 and A33like 3. Also described are methods of detecting cancers expressing these polypeptides, and methods and kits for diagnosing said cancers, and methods of inhibiting effects of a cancer in a patient.
    Type: Application
    Filed: October 23, 2003
    Publication date: December 28, 2006
    Applicant: Ludwig Institute for Cancer Research
    Inventors: Matthew Scanlan, Cynthia Scanlan, Gerd Ritter, Lloyd Old, Achim Jungbluth
  • Publication number: 20060089303
    Abstract: Cancer-testis (CT) antigens have been identified by screening public databases for transcripts that are expressed in tumor tissues and a limited set of normal tissues, or by screening for genes that are expressed in cancer and testis tissues (but not other normal tissues). The invention relates to nucleic acids and encoded polypeptides which are CT antigens expressed in patients afflicted with cancer. The invention provides, inter alia, isolated nucleic acid molecules, expression vectors containing those molecules and host cells transfected with those molecules. The invention also provides isolated proteins and peptides, antibodies to those proteins and peptides and cytotoxic T lymphocytes which recognize the proteins and peptides. Fragments of the foregoing including functional fragments and variants also are provided. Kits containing the foregoing molecules additionally are provided.
    Type: Application
    Filed: September 29, 2005
    Publication date: April 27, 2006
    Applicants: Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
    Inventors: Lloyd Old, Matthew Scanlan, Cynthia Scanlan, Yao-Tseng Chen
  • Publication number: 20050063981
    Abstract: The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.
    Type: Application
    Filed: December 4, 2003
    Publication date: March 24, 2005
    Inventors: Dirk Jager, Elisabeth Stockert, Barry Picker, Matthew Scanlan, Cynthia Scanlan, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-Tseng Chen